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CHAPTER I 
 
INTRODUCTION 
 
Host response to biomaterials 
Biomedical implants that facilitate communication and interaction with the surrounding tissue and 
circulatory system are rendered ineffective by the huge diffusion barrier and increased electrical 
resistance presented by the fibrous capsule [1, 2]. For successful implants, it is ideal to have the device 
surrounded and penetrated by highly vascularized tissue [3]. Angiogenesis occurs naturally in 
reproduction, wound repair, placental development, and the foreign body response to form new blood 
vessels from activated vascular endothelial cells (ECs). When grown on a biomaterial, ECs migrate, 
associate, and elongate into tubule structures that resemble immature budding capillaries during 
angiogenesis [4]. Both angiogenesis and inflammation are inescapable in vivo responses to all 
biomaterial implants, and there is emerging evidence that inflammatory cells regulate the functions of 
endothelial cells related to angiogenesis [5, 6]. Although these processes are thought to be related in 
fields such as cell biology, cancer, cardiovascular medicine, immunology, and pathophysiology, the 
interconnectivity of these two processes is not understood well in the field of biomaterials research [5-10]. 
  
Biomaterial design and fabrication 
One key aspect of biomaterial applications for clinical implants is that the surface, internal, micro, 
and macro properties of biomaterials should be biomimetic to be compatible with the natural extracellular 
environment. On the other hand, modification of even one biomaterial parameter can affect cellular 
behavior and the subsequent physiological outcome. For example, increased roughness of biomaterial 
surfaces enhances the adhesion and growth of ECs [11, 12], suggesting the possibility of controlling 
angiogenesis via modification of biomaterial surface parameters. Hydrogels are often thought to be 
relatively tissue-compatible, most likely due to their properties resembling living tissue, such as high water 
content and elasticity [13, 14]. Studies have also shown that implants with increased water content inhibit 
the adhesion of macrophages, and therefore, may affect the inflammatory response [15]. A unique type of 
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polyethylene glycol (PEG)-cross-linked tyrosine-derived polycarbonate hydrogels have been synthesized 
and characterized. These polymeric hydrogels have controllable crosslink and degradation properties and 
can be easily fabricated into porous scaffolds, because studies have shown that a porous structure is also 
important to controlling inflammatory responses and vascularization [16, 17]. Tyrosine-derived 
polycarbonates are tissue-compatible, exhibit desirable mechanical properties, and are hydrophobic with 
a slow degradation rate [18]. Chemically cross-linking with PEG produces hydrolytically degradable 
hydrogels to facilitate cell interactions and accelerate wound healing [13, 19].  
 
Bioactive synthetic peptides 
Hydrogel scaffolds can be made more bioactive by introducing synthetic peptides that are derived 
from extracellular matrix (ECM) components. Studies have shown that peptides from laminin-1 (an ECM 
protein composed of three chains -- α1, ß1, and γ1) can promote angiogenesis in vivo [20, 21]. One of the 
most potent sites from laminin-1 is peptide C16 from the γ1 chain (Table 1). This peptide promotes EC 
adhesion, tube formation, and angiogenesis. The C16Y peptide was made through one amino acid 
substitution in the C16 sequence (Table 1) and showed strong inhibition of angiogenesis in vivo [20]. On 
the other hand, a tetrapeptide, Ac-SDKP (Table 1), has been identified as an anti-inflammatory cytokine, 
decreasing macrophage infiltration and TGF-β expression [22-25]. This peptide is normally present in 
organs and biological fluids.  
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Table 1. Sequence and Function of Synthetic Peptides 
Peptide  Activity  Sequence  
C16  Pro-angiogenic  Lysine-Alanine-Phenylalanine-Aspartic acid-Isoleucine-Threonine- 
Tyrosine-Valine-Arginine-Leucine-Lysine-Phenylalanine.  
C16Y  Anti-angiogenic  Aspartic acid-Phenylalanine-Lysine-Leucine- Phenylalanine 
-Alanine-Valine-Tyrosine-Isoleucine-Lysine-Tyrosine-Arginine  
C16L  Scrambled, control 
peptide for C16 and 
C16Y, inactive  
Leucine-Threonine-Phenylalanine-Arginine-Alanine-Lysine-Valine- 
Tyrosine-Phenylalanine-Isoleucine-Lysine-Aspartic acid  
Ac-SDKP  Anti-inflammatory  N-acetyl-serine-Aspartic acid-lysine-proline  
Ac-DKSP  Scrambled control 
peptide for Ac-SDKP, 
inactive  
N-acetyl-Aspartic acid-lysine-serine-proline  
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CHAPTER II 
 
PARSING INFLAMMATORY CUES IN ANGIOGENESIS USING BIOACTIVE HYDROGELS 
 
Introduction 
To investigate the role of biomaterial-induced inflammation in angiogenesis and the related 
mechanisms, it is important to investigate how the interaction of inflammatory cells with the biomaterial 
affects endothelial cell responses. The goal of this study is to address the hypothesis that the 
inflammatory response to biomaterials may regulate angiogenic activities in biomaterial implants. To 
investigate this hypothesis, polyethylene glycol (PEG)-cross-linked tyrosine-derived polycarbonates were 
used to fabricate porous hydrogel scaffolds. The porous structure, mechanical properties, degradation 
profile, and protein adsorption of these hydrogel scaffolds were characterized through a series of tests. 
Peptides, including C16 (pro-angiogenic), C16Y (anti-angiogenic), Ac-SDKP (anti-angiogenic) and their 
scrambled controls were hybridized with ECM gels to the hydrogel scaffolds to control angiogenic and 
inflammatory processes. The release of peptides from the ECM gel-filled hydrogel scaffolds was 
measured using high performance liquid chromatography (HPLC). These peptide filled ECM-gel 
hydrogels were also used for in vitro biological studies with ECs and macrophages individually and in co-
culture, as well as for in vivo studies to investigate the interplay between inflammation and angiogenesis.  
 
Methods 
 
Fabrication and characterization of hydrogels  
 -Polymers and cross-linking: A series of copolymers of X mole % desaminotyrosyl tyrosine ethyl ester 
(DTE) and Y mole % desaminotyrosyl-tyrosine (DT) (X+Y =100%), were identified as poly(x%DTE-co-
y%DT carbonate) (Figure 1A) [26]. For a given value of Y (%), the extent of cross-linking can be changed 
by reacting 0 to 100% of the free carboxylic acids with amine groups of polyethylene glycol dihydrazides 
(PEG dihydrazides; Mw =2,000).  
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-Fabrication and imaging of porous structure: Macro-and micro-pores were generated following 
the previously reported procedures [26].  Briefly, macro-pores were generated through salt leaching. 
Micro-pores were created by evaporation of phase-separated organic solvent domains through 
lyophilization. The pore structure and interconnectivity were characterized by imaging with scanning 
electron microscopy (SEM) and optical coherence tomography (OCT).  
-Peptide loading through hybridization of ECM gel: Functional and control molecules, i.e. pro-
angiogenic C16, anti-angiogenic C16Y, anti-inflammatory Ac-SDKP, pro-inflammatory lipopolysaccharide 
(LPS), and various scrambled peptide controls (Table 1) were incorporated into the hydrogel scaffolds by 
hybridization, i.e. filling the pores with a solution of a gel-forming ECM component (either collagen or 
fibrin) that contains the peptides [20-23, 27]. All peptides were obtained from GenScript (Piscataway, NJ). 
To evaluate the stability of the hydrogel-ECM gel association, hydrogels were embedded in collagen 
solution (3.1 mg/ml; Chemicon, Rosemont, Illinois) and imaged before and at 7 days post collagen gel 
formation with a variable geometry Skyscan 1172 Microtomograph (Micro-CT) unit with a 10W X-ray 
source (Micro Photonics Inc., Allentown, PA). The X-ray source was set to 45kV for optimal imaging of 
polymer scaffold-collagen constructs.  
 
Mechanical testing of hydrogel scaffolds 
For mechanical testing, hydrogel scaffolds were hybridized with collagen and tested in 
compression on an Instron Model 5D Materials Testing Machine (Norwood, MA). The specimens were 
compressed at a crosshead speed of 0.5mm/min and the stress vs. strain curve was recorded. The 
Young’s modulus was calculated as the slope of the linear portion of the stress-strain curve (n=3). 
 
Degradation of hydrogel scaffolds 
Hydrogel scaffold degradation was profiled by HPLC over time after incubating hydrogel scaffolds 
in phosphate buffer saline (PBS) at 37°C [28]. The PBS supernatant was treated with 1N NaOH to 
hydrolyze the polymer fragments to DT. The amount of DT was measured by HPLC (Waters Corporation, 
Milford, MA), and the concentration of was determined from a standard calibration curve. Samples were 
collected at days 0, 3, 7, 21, and 28 (n=3). 
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 Protein adsorption on hydrogel scaffolds 
Gold quartz crystals (QSX 301, Q-Sense, Sweden) were spin-coated with a mixture (1% 
weight/volume) of poly(90%DTE-co-10%DT carbonate) and PEG-dihydrazide (0, 8 or 20%) as described 
previously [29]. PBS was run through each chamber until an equilibrium baseline was established. 
Fibrinogen (0.3 g/ml) in PBS was then run at a flow rate of 24.2 L/min for 2 hours. A PBS rinse was 
performed for 1 hour to remove any reversibly adsorbed proteins. The Voigt model in Q-Tools (Q-Sense) 
was used to model overtones 3-9 to obtain the adsorbed mass (μg/cm
2
) (n=3) using the previously 
described methods.[30, 31]   
 
 Peptide release from ECM gel filled hydrogel scaffolds 
Hydrogel scaffolds hybridized with a mixture of peptides and collagen or fibrin (75µg of 
peptide/hydrogel, n=4) were incubated in PBS at 37°C for 3, 7, or 14 days. As all peptides in the “C16 
family” (C16, C16Y, and C16L) are composed of the same number (12 amino acids) and composition of 
amino acids with different sequences, these are referred to as “long peptides.” All the peptides in the “Ac-
SDKP family” are four amino acids long, but in different sequences, so these are referred to as “short 
peptides.” The name, sequence, and source of these peptides are found in Table 1. The supernatant was 
collected at the end of the time point and the released peptides were detected by HPLC using a Xterra® 
RP18 column (Waters) with a flow rate of 1µL/min at 37°C at 220nm detection wavelength. A gradient 
was created starting with 100% mobile phase A (0.1% TFA in water) for 2 minutes and gradually 
changing to 95% mobile phase B (90% methanol with 0.1% TFA in water) at 15 minutes. This 
composition is held for one minute then increased to 100% mobile phase B after an additional minute. 
The amount of released peptides was calculated based on a standard curve made from unknown 
concentrations of peptides ranging from 0 to 75µg/mL using Breeze™ software (Waters).  
 
 Cell culture and collagen-hydrogel format for in vitro cell assays  
Human umbilical vein ECs (HUVECs) were obtained from Cambrex (East Rutherford, NJ) and 
cultured in a standard EC growth medium [32]. Human blood-derived monocytes (HBMs) were obtained 
from Advanced Biotechnologies (Columbia, MD), and seeded at a density of 2x10
7
 cells/10mL of DMEM 
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(Invitrogen, Carlsbad, CA) with 20% fetal calf serum (Intergen, Purchase, NY), 10% human serum (Nabi, 
Boca Raton, FL), and 5µg/mL macrophage colony-stimulating factor (Sigma Aldrich, St. Louis, MO) for 9 
days to differentiate into macrophages [33]. For all in vitro cell assays, the collagen gel samples were 
prepared, some with and some without the embedding of peptides (see section 2.1). The gel-peptide 
complex was hybridized with porous hydrogel scaffolds made from poly (DTE-co-10%DT carbonate) with 
8% PEG crosslinker.  
 
In vitro angiogenic and inflammatory activities from culture of single cell types in peptide and collagen-
filled hydrogel scaffolds  
-HUVEC migration: HUVECs (2 x 10
4
/ scaffold) were labeled with Hoechst 33258 nuclear stain 
(Sigma) and seeded onto the top surface of collagen-hydrogel scaffolds with or without C16 (75μg). 
Three-dimensional HUVEC migration from gel surface into the scaffold pores was imaged at 0 and 72 
hour(s) post seeding using optical sectioning (3µm intervals) with a Leica TCS SP2 multi-photon 
microscope system (Wetzlar, Germany). The number of cells that migrated into scaffolds was calculated 
as a ratio to non-migrating cell population on the surface (n=5). Proliferating cells were visualized by 
BrdU staining, according supplier’s protocol (Chemicon).  
- Tubulogenesis: HUVECs (2.5 × 10
5
/ scaffold) were cultured for 72 hours on collagen-hydrogel 
scaffolds with C16 peptides (0, 25, 50, or 75μg). The range of the peptide concentration was determined 
following the previous study [27]. The nuclei were stained with ethidium bromide (red, Invitrogen, 
Carlsbad, CA) and the actin cytoskeleton was visualized by FITC-phalloidin (green, Invitrogen). The cells 
were imaged with a multi-photon confocal microscope and tube length measured using Microsuite 
software (AnalySIS, Olympus, Germany) (n=5) [26]. 
- Phagocytosis: Macrophages (1 × 10
5
/ scaffold) were cultured for 24 hours on collagen-hydrogel 
scaffolds with lipopolysaccharide (LPS; 100ng) as a positive control or Ac-SDKP peptides (0, 25, 50, or 
75μg). The cells were treated with green-fluorescent Escherichia coli (E. coli) particles for 2 hours 
according to manufacturer protocol using Vybrant® Phagocytosis assay kit (Invitrogen), counter – stained 
with Hoechst, and imaged with a multi-photon confocal microscope (Leica TCS SP2) [34, 35]. The green 
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fluorescence intensity was measured and normalized to the corresponding cell number using Image J 
(NIH) (n=5).   
 
Co-culture of human monocytes and HUVECs on collagen-hydrogel scaffolds 
Macrophages (2 x 10
5
/scaffold) were mixed with collagen solution, cell culture media, and 
peptides (75µg for C16, C16L, Ac-SDKP, and Ac-DKSP peptides) or LPS (1µg) and this complex was 
hybridized to a hydrogel scaffold by incubating for 2-3 hours to allow gelation. HUVECs (2x10
5
/scaffold) 
(Cell Applications, San Diego, CA) were seeded on top of the collagen-hydrogel scaffolds in a 50:50 
mixture of macrophage and endothelial cell media.  After three days, macrophages were analyzed for 
phagocytic activity using Vybrant® Phagocytosis assay kit. Samples were fixed and HUVECs were 
stained for vascular cell adhesion molecule-1 (VCAM-1) using APC conjugated anti-human CD106 
antibody (BioLegend, San Diego, CA). Cells were counted by Hoechst nuclear stain. Hydrogels were 
imaged using Olympus FV 1000 inverted confocal microscope (Center Valley, PA) and images were 
analyzed for the number of tube formations, average green fluorescence intensity (phagocytosis), and the 
number of VCAM-1-positive cells per 300μm x 300μm imaged area (n=8).  
 
In vivo angiogenesis and inflammatory activation in implanted collagen-hydrogel scaffolds 
Collagen-hydrogel scaffolds containing LPS (100ng) or functional peptides (0 or 75μg) were 
sandwiched between two nitrocellulose filters (Millipore, Billerica, MA) to constrain nonspecific tissue 
growth within the scaffolds to two dimensions [9]. The scaffolds were then implanted subcutaneously in 
the dorsal regions of mice (129 SvEv) for 7 days. After sacrificing the mice, their vasculature was 
perfused with 10mL heparinized saline containing 0.1µm fluorospheres by injection into the left ventricle 
[10, 36]. Scaffolds were harvested and vasculature was visualized with multi-photon microscopy and 
quantified by dissolving the microspheres in xylene and measuring the fluorescence intensity using a 
plate reader (Tecan, Durham, NC) [10, 36]. At the same time, the phagocytosis activity was measured 
using Vybrant® Phagocytosis assay kit (see the section 2.7). The expression of F4/80 membrane-bound 
antigens on inflammatory cells infiltrated into implants was detected by immunohistochemistry of frozen 
sections from the harvested scaffolds using Alexa Fluor 594-conjugated rat anti-mouse F4/80 monoclonal 
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antibodies (Abcam, Cambridge, MA). The fluorescence intensity was measured and normalized to the 
corresponding total cell number, measured by Hoechst (n=6) [9]. 
 
Statistical analysis 
In all experiments, analytical results were expressed as means ± standard error. Comparisons of 
individual sample groups were performed using unpaired student’s t-test. For all statistics, p<0.05 was 
considered statistically significant. 
 
Results 
 
 Fabrication of porous hydrogel scaffolds 
Hydrogels were successfully fabricated with varying DT content (0 and 10%) and PEG 
dihydrazide cross-linker composition (0, 8, 20, and 40%). We characterized this new hydrogel system for 
pore structure, collagen gel stability, modulus, degradation profile, and protein adsorption. SEM and OCT 
revealed a highly porous, interconnected structure with controllable macro-pores between 212 and 
425µm formed by salt leeching (Figure 1b and c).  To ensure that the collagen gel maintained stability 
over time, micro-CT of a collagen-gel filled hydrogel scaffold at 7 days post hybridization (right) was 
compared to an unfilled hydrogel scaffold (left) (Figure 1d). The pores (white area), which were observed 
dominantly on the surface before embedding, were stably filled with collagen gel (black area) at 7 days 
post-embedding.  
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Figure 1. Characterization of hydrogel scaffolds. A. Chemical structure of poly (X%DTE-Y%DT carbonate) with polyethylene 
glycol (PEG)-dihydrazide cross-linker. The free carboxyl group (arrow) of DT forms an amide bond with the amine group (arrow) of 
PEG-dihydrazide for cross-linking polymer chains. X and Y indicate molar percentages of DTE and DT, respectively, with 0-100% 
variation in each unit (X+Y=100%). The cross-linking degree with PEG-dihydrazides can vary from 0 to 100% for available Y%DT. 
B. SEM image showing surface view of the pore architecture in a hydrogel scaffold. Scale bar=150µm. C. OCT image showing the 
3D interconnectivity of pores in a hydrogel scaffold (2mmx2mm scan). Blue=pores, yellow=scaffold. D.  Micro CT scan images 
showing the whole surface of the hydrogel (diameter = 0.6 cm) without (left) and with (right) collagen gel at 7 days post hybridization 
of collagen gel. White area = pores; black area = collagen gel or polymers. 
 
Mechanical testing of hydrogel scaffolds 
For mechanical tests, hydrogel scaffolds with 0, 8, 20, and 40% PEG cross-linker were 
compressed and the slope of the stress versus strain curve was measured (Young’s modulus, Figure 2a). 
The inclusion of the PEG cross-linker in an 8% molar ratio increased the modulus of the hydrogel 
scaffolds, as compared to hydrogel scaffolds with 0% PEG dihydrazide. However, the modulus decreased 
significantly as the cross-linking degree further increased from 8% to 20% and to 40%. Hydrogels with 
40% cross-linking had a Young’s modulus that was not statistically different from those with 0% cross-
linking. The degradation rate of hydrogel scaffolds, as indicated by the cumulative release of DT (a major 
degradation product) was dependent on the degree of cross-linking (Figure 2b). There was no significant 
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difference in the amount of released DT among the hydrogel scaffold types tested until 20 days 
incubation in PBS. After 28 days, the largest amount of DT was released from non-crosslinked hydrogel 
scaffolds, indicating faster degradation of 0% crosslinked hydrogel scaffolds than other scaffold types with 
higher cross-linking degrees.  The 40% cross-linked hydrogels released the least amount of DT from 20 
to 28 days, confirming a role of cross-linking in slowing the degradation rate of hydrogel scaffold.   
To investigate the interplay between PEG and negatively-charged DT in modulating protein 
adsorption on polymer surfaces, fibrin adsorption to the polymer surface was measured using QCM-D 
(Figure 2a).  As the PEG molar ratio increased from 0 % to 8% and to 20% in mixture with poly(90%DTE-
co-10%DT carbonate), fibrin adsorption significantly decreased, confirming a repellent effect of PEG on 
fibrin adsorption [29]. On the other hand, copolymerization of 10% DT significantly increased fibrin 
adsorption, compared to pure poly (DTE carbonate), indicating a potential effect of negatively charged 
carboxyl groups on increased protein adsorption.   
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Figure 2. Mechanical properties, degradation, and protein adsorption of hydrogel scaffolds.  A. Young’s modulus obtained 
from compression testing of collagen-filled hydrogel scaffolds. Hydrogel scaffolds with 0, 8, 20, or 40% cross-linking with PEG 
dihydrazides were compressed at a constant rate. The Young’s modulus was calculated (MPa) from the slope of stress versus strain 
curve (n=3). B. Degradation profiles of hydrogel scaffolds. Hydrogel scaffolds were incubated in PBS at 37°C and supernatant was 
collected for analysis by HPLC (n=3). C. Protein adsorption on polymers with increasing percentages of PEG dihydrazide. A mixture 
of polymer and PEG-dihydrazide was spin-coated on a quartz crystal, incubated with fibrinogen in PBS at 37°C, and the thickness of 
adsorbed protein layer on each polymer sample was measured through QCM-D (n=3). a-c)*p<0.05 vs. all other groups in the same 
graph.  
 
Peptide Release from ECM gel filled hydrogels 
Cumulative release of the peptides from the ECM gel-hydrogel scaffold was measured by HPLC 
(Figure 3). Hydrogel scaffolds were filled with collagen or fibrin gels containing 75µg of peptide and 
incubated in PBS. The supernatant was collected and the amount of released peptides was measured 
over time by HPLC. C16L and Ac-DKSP peptides were used as the representative peptides of the long 
peptides (C16 family with 12 amino acids) and the short peptides (acetylated tetrapeptide family), 
respectively. Peptides were released from hydrogel scaffolds in a burst, with an initial high release 
following a logarithmic pattern, followed by a slower lag phase. This pattern is typical of most drug 
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release. The long peptides showed a higher initial release, but after 14 days both peptides released 
almost the same amount. Both types of peptides showed more release from collagen-filled hydrogel 
scaffolds than fibrin-filled hydrogel scaffolds, therefore collagen-filled hydrogel scaffolds were used in all 
further in vitro and in vivo tests.  
 
Figure 3. Peptide release from collagen or fibrin-filled porous hydrogel scaffolds. Cumulative release of a. the representative 
type (C16L) of long peptide types and b. the representative type (Ac-DKSP) of short peptides. Peptide release from collagen or 
fibrin filled scaffolds at days 1, 3, 7, and 14 post incubation in PBS was measured using HPLC (n=4).  
 
In vitro testing of pro-angiogenic effect on EC migration and tubulogenesis 
A significant number of HUVECs migrated from the surface into the collagen-hydrogel scaffolds 
for 72 hours after seeding (Figure 4a). The hybridization of pro-angiogenic C16 enhanced the HUVEC 
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migration into internal layers of collagen-hydrogel scaffolds. The confocal images and corresponding 
graph in Figure 4b show more cells around 80µm into the collagen-hydrogel scaffold with the C16 peptide 
(75µg) than without this peptide. To further investigate the pro-angiogenic effect of the C16 peptides, 
HUVECs seeded in collagen-hydrogel scaffolds with C16 peptides were incubated for 72 hours and 
analyzed for the total length of tubes formed by HUVECs. The total tube length increased significantly in a 
step-wise pattern as the peptide concentration increased from 0 to 75µg (Figure 4c). The maximum 
tubulogenic activity was observed at the highest peptide concentration (75μg).  
 
In vitro testing of anti-inflammatory effect on macrophage activation 
Monoctyes were differentiated into macrophages for in vitro testing because macrophages are 
adherent cells while monocytes are non-adherent. Phagocytic activity was visualized as green 
fluorescence and quantified by normalizing to corresponding cell number. The green-fluorescence 
intensity increased upon treatment with LPS (Figure 4d, left picture), and dramatically decreased upon 
the introduction of anti-inflammatory Ac-SDKP (75μg) (Figure 4d, right picture). Phagocytosis activity 
decreased significantly in a step-wise pattern as the peptide concentration increased from 0 to 75µg. The 
minimum phagocytosis activity was seen at the highest concentration of Ac-SDKP (75μg). 
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Figure 4. In vitro responses of HUVECs and macrophages to peptide- loaded collagen-hydrogel scaffolds. A and B. HUVEC 
migration into scaffolds. Cell nuclei were stained with Hoechst (blue) and proliferating cells were identified by BrdU staining (green). 
A. Z-sectional projection of HUVEC migration from the surface (red line). B. Effect of C16 peptide on HUVEC migration at 72 hours. 
C. Tube length (µm) with different doses of pro-angiogenic C16 peptides. D. Phagocytosis of macrophages. The top fluorescence 
images show macrophages (blue nucleus) phagocytizing E. coli particles (green) under treatment of LPS (100ng) without (left) or 
with (right) anti-inflammatory Ac-SDKP (75ug). The phagocytosis activity (green fluorescence intensity normalized to cell number, 
bottom graph) under treatment with LPS (100ng) or different doses of Ac-SDKP peptides c)- d) n=5. Scale bar = 100μm. b-d) *p< 
0.05 vs. all the other groups in the same graph.  
 
Co-culture of macrophages and HUVECs on collagen-hydrogel scaffolds 
HUVECs were seeded on top of collagen-hydrogel scaffolds. Macrophages were included inside 
the collagen gel for co-culture. Phagocytosis activity (Figure 5a, left), tubulogenesis (Figure 5a, right), and 
endothelial cell activation (Figure 5e) were quantified through image analysis. Tubulogenesis was defined 
as any three or more VCAM-1 (a marker of activated endothelial cells) expressing cells joined together to 
form a tube [37]. The two activities, tubulogenesis and phagocytosis, showed very similar trends in 
response to the various combinations of peptides. The combination of Ac-SDKP with C16 decreased 
phagocytosis as well as tubulogenesis compared to C16 alone. Similarly, the combination of C16Y with 
LPS decreased tubulogenesis as well as phagocytosis compared to LPS alone. The addition of LPS to 
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C16 increased both phagocytosis and tubulogenesis compared to C16 alone, and the addition of Ac-
SDKP to C16Y decreased both phagocytosis and tubulogenesis compared to C16Y alone. These results 
indicate an interconnection and a potential feedback mechanism between macrophages and HUVECS in 
response to biomaterial implants.     
VCAM-1 expression has been implicated in EC activation and recruitment of inflammatory cells 
[32]. The expression of VCAM -1 in HUVECs significantly decreased when anti-inflammatory Ac-SDKP 
peptides were present in addition to pro-angiogenic C16 peptides, compared to C16 alone (Figure 5d). 
The number of cells expressing VCAM-1 also decreased in the presence of both C16Y and LPS 
compared to LPS alone.  These results also indicate an interconnected relationship between 
angiogenesis and inflammation, as well as a potential causative role of macrophages in EC 
tubulogenesis.  
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Figure 5. In vitro co-culture of macrophages and HUVECs with combinations of peptides in collagen-hydrogel scaffolds. A. 
Fluorescence images showing activated macrophages phagocytizing E.coli particles (green, top left) and HUVECs with VCAM-
1staining (red, top right). Scale bar=50μm. B. Tubulogenesis of HUVECs. The number of spots showing three or more VCAM-1 
positive ECs joined together to form a “tube” was measured in image fields. C. Phagocytosis (average green fluorescence per 
image field) of macrophages. D. Inflammatory activation of HUVECs. The number of VCAM-1-positive HUVECs was measured in 
image fields. b-d) n=8. b-c)*p<0.05 vs. control (C16L).  
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In vivo subcutaneous implantation of collagen-hydrogel scaffolds 
In order to test the effects of LPS and Ac-SDKP on activation of inflammatory cells, F4/80 
expression was measured in collagen-hydrogel scaffolds implanted subcutaneously in mice for seven 
days. Red fluorescence intensity from immunostaining of F4/80 antigens was measured and normalized 
to cell number. Treatment with LPS showed the highest level of F4/80 expression while treatment with 
anti-inflammatory Ac-SDKP showed the lowest level of F4/80 expression (Figure 6a and b). The addition 
of pro-angiogenic C16 to collagen-hydrogel scaffolds increased the number of F4/80-positive cells, 
compared to the conditions with anti-inflammatory Ac-SDKP or without peptide treatment.  
The formation of new blood vessels (red) and the phagocytosis of inflammatory cells (yellow-
green) in implanted collagen-hydrogel scaffolds were also visualized and quantified (Figure 6c).   
Compared to implants with no peptide, addition of anti-inflammatory Ac-SDKP to collagen-hydrogel 
scaffolds significantly decreased the number of phagocytosing cells as well as the level of connectivity 
and branching of vasculature. However, these activities significantly increased when C16 peptides were 
present in the implants (Figure 6c top). Quantification of vascular perfusion capacity and phagocytosis 
(Figure 6c top and bottom graphs, respectively) showed similar patterns, in which the implants with Ac-
SDKP peptides showed significantly lower levels of the phagocytosis activity and perfusion capacity, 
compared to the implants with C16 peptides or no treatment. On the other hand, a C16-mediated 
induction of angiogenesis significantly increased the phagocytosis activity compared to the other test 
groups. These results showed the two-way communication between inflammatory cells and ECs in vivo 
and show that they regulate each other in response to biomaterial implants.  
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Figure 6. In vivo angiogenesis and inflammatory cell activation with peptides in collagen-hydrogel scaffolds. A. 
Fluorescence images showing F4/80-positive macrophages (red) out of cells (blue nuclei) infiltrated into implanted scaffolds with 
LPS (100ng) (top left), C16 (75μg) (bottom left), Ac-SDKP (75μg) (bottom right), or no peptide (top right). B. The intensity of red 
fluorescence (F4/80) was normalized to the corresponding cell number (graph), indicating the degree of macrophage activation. C. 
Fluorescence images showing new blood vessels (red), which were visualized by fluorescent microangiography, and macrophages 
phagocytosing E.coli particles (yellowish green) in scaffold implants with no peptide (top left), C16 (75μg) (top middle), or Ac-SDKP 
(75μg) (top right). Scale bar = 100μm. b-c) *p< 0.05 vs. a control group (no peptide or LPS). 
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Discussion 
The primary goal of this study was to elucidate a mechanism of communication between 
angiogenesis and inflammation in biomaterial implants. The results indicate that angiogenesis and 
inflammation are interconnected through feedback mechanisms. In particular, the causative roles of 
inflammatory cell activation in angiogenesis are evident by effects of pro-or anti-inflammatory molecules 
on angiogenic activity.  This feedback relationship must be taken into consideration when optimizing the 
host response to biomaterial implants. This study suggests that the host immune response should be 
properly preserved and controlled to enhance angiogenesis for functional survival of biomaterial implants.   
A series of PEG-cross-linked tyrosine-derived poly (X%DTE-co-Y%DT carbonates) provided a 
modifiable template for creating porous hydrogel scaffolds through salt leaching and phase separation. 
These scaffolds proved to be highly porous, with a high degree of interconnectivity that aided oxygen and 
nutrient transport, cell growth, and migration into internal layers of hydrogel scaffolds.  Unlike many 
common hydrogels, which become stiffer as cross-linking degree increases, these hydrogels become 
more hydrophilic and compliant with increasing crosslink density most likely due to increased water 
absorption by PEG-cross-linkers [26, 38]. As the PEG content increased from 0% to 8% and to 20% in 
the mixture with (90%DTE-co-10%DT carbonate), the thickness of the accumulated fibrin layer 
significantly decreased, confirming the PEG-mediated repellent effect on protein adsorption [39, 40]. The 
cross-linking density also influences the degradation rate, which is important for controlling angiogenesis 
and tissue regeneration. Increasing the cross-linking density decreased the degradation rate of the 
hydrogel scaffold. This is most likely due to increased covalent bonds formed among polymer chains 
through cross-linking, which slow the disintegration rate of the hydrogel.  These hydrogel scaffolds can 
serve as a unique system for studying angiogenesis and inflammation by controlling the crosslink density 
and pore structure, thereby controlling the mechanical properties and degradation rate.  
Introduction of synthetic peptides, pro-angiogenic C16, anti-angiogenic C16Y, control peptide 
C16L, and anti-inflammatory Ac-SDKP, as well as the pro-inflammatory molecule LPS, allowed for the 
control of inflammation and angiogenesis. These peptides were incorporated into the hydrogel by 
hybridization with a collagen gel, which proved to remain stable over time, allowing sustained release of 
the peptides from the collagen-hydrogel scaffolds. The peptides used in this study came from two distinct 
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groups: long peptides (including C16, C16Y, and C16L) and short peptides (including Ac-SDKP and Ac-
DKSP). Both types of peptides were released from the scaffold in a sustained manner over time, but long 
peptides showed a faster burst release than the short peptides. After 14 days, however, both short and 
long peptides released almost the same amount. This sustained release allows cells to be exposed to 
peptides extended periods of time. The pro-angiogenic effect of the C16 peptide was verified by the 
increase in endothelial cell migration into the scaffold, and the increase in tube formation compared to 
conditions without C16 peptide. Collagen-filled hydrogel scaffolds with Ac-SDKP reduced phagocytosis, 
compared to scaffolds without Ac-SDKP or with pro-inflammatory LPS.   
When macrophages and ECs were co-cultured in peptide and collagen-filled hydrogel scaffolds, 
the same trend in both EC tubulogenesis and macrophage phagocytosis was observed in response to 
variations in the types and combination of functional peptides, indicating interconnectivity between the 
two cell activities (Figure 5). In the presence of anti-inflammatory Ac-SDKP, both phagocytosis and 
tubulogenesis decreased while both activities increased in the presence of pro-angiogenic C16. In 
response to the combination of anti-angiogenic C16Y with anti-inflammatory Ac-SDKP, both phagocytic 
activity and tubulogenesis were minimized, while both activities were maximized in response to the 
combination of pro-antiogenic C16 with pro-inflammatory LPS. C16, with or without the addition of pro- or 
anti-inflammatory molecules, induced higher levels of both tube formation and phagocytic activity than 
C16Y, with or without the addition of pro-or anti-inflammatory molecules, indicating that although 
angiogenesis increased upon the addition of pro-inflammatory LPS and decreased upon the addition of 
Ac-SDKP, these changes cannot fully compensate for the effects of pro-angiogenic C16 and anti-
angiogenic C16Y. These results show that the communication between angiogenesis and inflammation is 
not one-sided. Moreover, the two-way feedback interactions between inflammatory responses and 
angiogenic processes suggest that elimination of host inflammatory responses through modification of 
biomaterial properties may impede tissue interactions with implants and further regeneration by impairing 
blood vessel formation.      
 In vivo experiments verified the cross-talk between angiogenesis and inflammation in biomaterial 
implants as collagen-hydrogel scaffolds containing anti-inflammatory Ac-SDKP had fewer activated 
phagocytic cells, but also revealed fewer functional blood vessels with less branching compared to 
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scaffolds with no peptide or C16 treatment. Collagen-hydrogel scaffolds containing pro-angiogenic C16 
recruited many phagocytic cells, particularly near the newly-formed blood vessels, and therefore showed 
significantly higher levels of perfusion capacity and phagocytosis activity compared to scaffolds 
containing Ac-SDKP. The same result was also observed in the immunohistochemistry analysis of 
excised implants. F4/80 antigen expression, as seen on a wide range of activated inflammatory cells (e.g. 
mature tissue macrophages) [41], was higher with C16 treatment than with no peptide or Ac-SDKP 
treatment. These results indicate that inflammatory cell response may contribute to the formation of intact 
functional blood vessels in the implants in vivo, but this response is not one-sided. Inflammatory cells 
influence ECs and ECs influence inflammatory cells in a bi-directional method of communication.  
 Emerging evidence points to the probability that inflammatory changes regulate the 
neovascularization that is associated with wound healing, tumor growth, and inflammatory disease, such 
as psoriasis, arthritis, and atherosclerosis. Inflammatory cells recruited to the inflamed or injured tissue 
can release growth factors as well as proteases capable of modulating tissue structure and promoting 
angiogenesis [5]. Several studies revealed that the degree of inflammation was related to the level of 
vascularization of the biomaterial implants [9, 10]. The pro-angiogenic vascular endothelial growth factor 
(VEGF) has potent vascular permeability-enhancing properties in addition to being a chemo-attractant for 
mononuclear cells. Activated human inflammatory cells, such as peripheral blood mononuclear cells and 
neutrophils, express VEGF [8, 42], indicating another inflammatory-mediated pathway important in 
angiogenic activities.  In future studies we will investigate the mechanism of this communication and 
identify how these specific factors play a role in inflammatory cell-mediated angiogenesis. The elucidation 
of a clear mechanism will provide an efficient and realistic paradigm of the interconnectivity of 
inflammation with angiogenesis for the functional survival of biomaterial implants. The current study 
provides a new concept for biomaterial design which utilizes flexible inflammatory parameters to control 
angiogenesis for the eventual success of therapeutic interventions.  
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CHAPTER III 
 
CONCLUSION 
 
A clear interconnectivity between angiogenic and inflammatory activities was found from in vitro 
and in vivo studies using bioactive hydrogel scaffolds hybridized with functional peptides, indicating an 
inflammatory mechanism regulating follow-up angiogenic processes in hydrogels.  This study suggests 
that the host immune response should be properly preserved and controlled to enhance angiogenesis for 
functional survival of biomaterial implants. Elucidating the mechanisms behind the communication of 
these two processes will provide a method for the optimization of host response to biomaterials.  
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